Daclatasvir/ribavirin/sofosbuvirLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36545-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：148 / 148

相关论文

共 50 条

[1] Daclatasvir/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2020, 1834 (1) : 93 - 93
[2] Ribavirin/sofosbuvirLack of efficacy: 5 case reports
Reactions Weekly, 2020, 1833 (1) : 337 - 337
[3] Ledipasvir/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 278 - 278
[4] Ledipasvir/sofosbuvirLack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 362 - 362
[5] Daclatasvir/sofosbuvirLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1911 (1) : 165 - 165
[6] Ribavirin/rituximab/sofosbuvirLack of efficacy and drug intolerance
Reactions Weekly, 2024, 2015 (1) : 377 - 377
[7] Daclatasvir/ribavirin/sofosbuvirSymptomatic anaemia: case report
Reactions Weekly, 2017, 1654 (1) : 116 - 116
[8] Daclatasvir/ribavirin/sofosbuvirDiabetes mellitus: case report
Reactions Weekly, 2019, 1762 (1) : 134 - 134
[9] Hydroxychloroquine/sofosbuvirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1941 (1) : 215 - 215
[10] Daclatasvir/ribavirin/sofosbuvirVarious toxicities and respiratory infection (first report with daclatasvir): 6 case reports
Reactions Weekly, 2019, 1754 (1) : 123 - 123

← 1 2 3 4 5 →